Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors

NEXT STORY
Day One Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
PREV STORY
Global mRNA Vaccine and Therapeutics Market – Analysis By Product, End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of Covid-19 (2021-2030)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Biohacking Market Forecasts and Outlook 2021-2028: Forensics Laboratories Segment Recorded Revenue Share of 28% in 2020, with High Product Adoption for Monitoring Patient Health Conditions

author_avatar
NASDAQ Market News

iBio Announces Closing of its Public Offering of Common Stock

author_avatar
NASDAQ Market News

Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020

author_avatar
NASDAQ Market News